Rated 4.9 Excellent 11,512 Reviews 

UraHEX: Prostate, Bladder & Blood-Flow Support

Slow stream. Up at 3 a.m. Softer mornings. Most men blame age. We call it Low Flow, and it starts when less blood reaches the prostate and bladder.

UraHEX supports all three links at once: the prostate, the bladder and the blood flow that feeds them. Six ingredients studied in men. Every dose on the label.

  • Supports healthy prostate function*
  • Supports full, complete bladder emptying*
  • Supports restful, unbroken sleep*
  • Supports healthy blood flow below the belt*
Comes with the 90-night protocol
Evening Routine card
Morning Count card + texts
10-Second Squeeze guide
120Nights
120-night money-back guarantee Run the full protocol and keep your count. Not happy by night 120? Text us and get every penny back, even if the bottles are empty.
Pygeum, one of the six: what 18 trials found
19%
fewer night-time trips
24%
less urine left behind
23%
stronger peak flow
Cochrane review of 18 trials and 1,562 men, pygeum vs placebo. These results are for pygeum alone, not for UraHEX. See all the research →
View full details

Don't Take Our Word for It. Read the Research.

Every ingredient is in UraHEX because it's been tested in men. These studies tested the ingredients on their own, not UraHEX as a finished formula.

Clinical reviewBeta-sitosterol
Cochrane review · 4 trials · 519 men

Better urinary symptom scores and flow than placebo.

Read the study →
Systematic reviewRye-pollen extract
MacDonald et al. · BJU International · 2000 · 444 men

More men reported improvement than on placebo, including fewer trips at night. The trials tested Cernilton, a rye-pollen extract.

Read the study →
Registry study, no placeboFrench pine bark
Ledda et al. · Minerva Medica · 2018 · 75 men

Leftover urine fell from 99 to 48 mL in 60 days at 150 mg a day, vs 94 to 61 mL with standard care alone.

Read the study →
Placebo-controlled trialFrench pine bark
Bratislava Medical Journal · 2019 · 53 men

Better sexual-function scores than placebo after three months.

Read the study →
Single-blind trialL-citrulline
Cormio et al. · Urology · 2011 · 24 men

12 of 24 men improved on a standard erection-hardness score with citrulline, vs 2 of 24 on placebo.

Read the study →
Clinical reviewPygeum
Cochrane review · 18 trials · 1,562 men

Night trips down 19%, leftover urine down 24% and peak flow up 23%, compared with placebo.

Read the study →
Placebo-controlled trialCranberry
Vidlar et al. · World Journal of Urology · 2016 · 124 men

At 500 mg a day, symptom scores improved 4.1 points over six months, vs 1.5 on placebo.

Read the study →
The Low Flow linkBlood flow review
Tarcan, Choi & Azadzoi · Int. J. Mol. Sci. · 2022

Men with urinary symptoms show lower bladder and prostate blood flow, and worse blood vessels go with worse symptoms.

Read the study →
The Low Flow linkMSAM-7 survey
Rosen et al. · European Urology · 2003 · 12,815 men

Urinary and bedroom problems show up together in men 50 to 80, even after accounting for diabetes, heart disease, blood pressure and cholesterol.

Read the study →
The pathwayFDA, 2011
FDA press release · October 2011

The FDA approved a once-daily medication for men's urinary symptoms that works on the nitric oxide pathway, after three clinical trials.

Read the release →
Why no saw palmetto

No saw palmetto. On purpose.

The biggest review of saw palmetto, 27 trials and 4,656 men, found it no better than placebo, alone or in blends. So we left it out and used the room for ingredients that held up.

See the review →

Small studies don't always carry over to everyone. That's why you get 120 nights to see for yourself.